Tianjin Institute Of Pharmaceutical Research—New Drug Safety Evaluation Center mainly carry out the following preclinic research: Pharmacology, toxicology, Pharmacokinetics, drug evaluation of bioengineering .
The center has 56 staff, three Phd and nine received master degree.
Drug safety evaluation: with the GLP standard to do nonclinical research of chemical drug,TCM and biodrug.
Pharmacology study: the center focus on the Pharmacology of heart and blood vessel drug, mainly include: Dissolve Embolism Drugs, anti-embolism drugs, anti-myocardial ischemia drug, anti-cerebral Ischemic drug, anti-heart failure drugs, anti-coagulation drug, anti hypertensive drug. They also study the Pharmacology of TCM, anti-inflammatory drugs, respiratory drug, Digestive System drug etc.
Pharmacokinetics study: carry out the preclinical research and toxic-kinetics study, supply preclinical research material to clinic trial study; cooperate with the clinic trial base to study the effect of the new drug.